ArticleStroke research and treatment2026

Real-World Evidence Assessment of the Risk of Nonfatal Stroke in Patients Prescribed SGLT2 Inhibitors.

Alessandra T Ayers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.